Merck’s Post

#Oncology innovators face challenges when launching new therapies in a highly fluid environment. Learn how #pharma companies can navigate harsh realities and achieve commercial success in oncology now and in future. Read now: https://bit.ly/4cXVSsG

Available for ESMO 2024 Support! As we gear up for ESMO 2024, I’m available to provide strategic insights and competitive intelligence support. Whether you need help with post-conference analysis, or timely reporting, I’m here to assist. Feel free to message me directly or schedule a quick call to explore how I can support your ESMO 2024 efforts. #ESMO2024 #CompetitiveIntelligence #Pharma #Oncology #StrategicInsights

The countdown is ON for Propel Launch Summit 🚀, a power-packed experience for leaders of market access and commercialization teams launching a product in the next 1-3 years. Propel Launch Summit is happening May 20-22, 2024 in Indianapolis. You don’t want to miss this! Propel is the only event of its kind–full of actionable insights, industry experts, and strategy sessions, all without the usual salesy, vendor hassles. Save your seat today! Register at propellaunch.com. #propellaunch #propellaunchsummit #biopharma #marketaccess #patientaccess #druglaunch #oncology #raredisease #cellandgenetherapy #celltherapy #genetherapy #complexconditions #rarediseases #launchsuccess #pharmalaunch #biopharmalaunch

#Oncology represents the largest segment in the #BioPharma industry, generating over $200 billion annually. Here's a quick peek at who's leading the pack after the first quarter of 2024 🚀 #PharmaData #BioPharmaData #BioPharmaMarket #PharmaIndustry

With over 25 years of experience in research, technology, and biotech, Noelle Gaskill of Mirati Therapeutics approaches the challenges of DCTs with a comprehensive perspective, prioritizing listening to research sites. Get a sneak peek into her #ACRP2024 session, where she shares tactical insights from collaborating with thought-leaders, regulators, and sites, aiming to launch a hybrid DCT interventional oncology trial this year. Learn more about Noelle's session in Anaheim > https://bit.ly/3T5ahLX #GoForIt #GoForEducation #ClinicalTrials #ClinicalResearch #ClinicalTrialDesign #DCT #DecentralizedClinicalTrials

Accelerated approvals, staying abreast of rapid changes in data and navigating regulatory intricacies further complicate the commercialization process for #oncology therapies. Consequently, challenges such as infrastructure, risk spend and communicating value emerge as significant challenges. In their latest article, EVERSANA’s experts provide considerations and innovative approaches for brands to enhance their commercialization strategies. Read now: https://ow.ly/4emF50QRnV0

Platform and basket trials allow researchers to explore multiple treatments or target multiple patient populations simultaneously under a single overarching master protocol. Ingrid Lönnstedt shares benefits and challenges of these methodologies: https://hubs.ly/Q02yWS4X0 #biotech #pharma #adaptivetrials #clinicaltrials #oncology

Stay ahead in the dynamic #Biopharma ecosystem with insights from Deloitte’s Health Forward blog. Dive into the key trends shaping tomorrow’s #Oncology and drug pricing policies.

Watch now as our panel of experts explore different pathway platforms and #EHR systems to help manufacturers better understand how community and academic #oncology providers “manage” drug regimens: https://lnkd.in/eQaGPqSw PRECISIONvalue PRECISIONxtract

In BioPharma Dive, MMIT’s Carolyn Zele explains how #pharma companies can use claims, lab, pathway and coverage data to target the specific payers and institutions impeding patient access to their #oncology therapies. Read the article: https://ow.ly/ctvf50PZgjF. #BPDOncologyRWD #RWD